Efficacy of Alcaftadine 0.25% (AGN-229666) for Once-daily Prevention of Cedar-Pollen Allergic Conjunctivitis: A Phase 3 Randomized Study

Autor:	Tetsuya Kawakita, Tomoko Hasunuma, David A Hollander, Paul J Gomes, Hiroshi Fujishima, Takuro Sekiya
Rok vydání:	2020
Předmět:	Adult Male Histamine H1 Antagonists Non-Sedating medicine.medical_specialty Cryptomeria Administration Ophthalmic Signs and symptoms law.invention 03 medical and health sciences 0302 clinical medicine Double-Blind Method Randomized controlled trial law medicine Humans Immunology and Allergy Prospective Studies Olopatadine Hydrochloride Conjunctivitis Allergic 030203 arthritis & rheumatology business.industry Imidazoles Allergens Benzazepines Middle Aged Olopatadine medicine.disease Dermatology Allergic conjunctivitis Cedar pollen Ophthalmology Treatment Outcome Histamine H1 Antagonists 030221 ophthalmology & optometry Pollen Female Ophthalmic Solutions Alcaftadine Once daily business medicine.drug
Zdroj:	Ocular Immunology and Inflammation. 29:1621-1626
ISSN:	1744-5078 0927-3948
Popis:	This study evaluated the efficacy and safety of once-daily Alcaftadine 0.25% (AGN-229666) for prevention of signs and symptoms of Japanese cedar-pollen allergic conjunctivitis. This was a single-ce...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d5ef9152582c43d6931e01341299432 https://doi.org/10.1080/09273948.2020.1760309 Zobrazit plný text záznamu